Ex-vivo expanded allogeneic γδT cells
IIT2020028-EC-3
Phase 1 mab active
Quick answer
Ex-vivo expanded allogeneic γδT cells for Non-Hodgkin's Lymphoma (NHL) is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Non-Hodgkin's Lymphoma (NHL)
- Phase
- Phase 1
- Modality
- mab
- Status
- active